stock

Dexcom Inc (DXCM)

0

Share

Stay up to date

DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.

Financial Statements

Key Info

  • Industry: Surgical and Medical Instrument Manufacturing
  • Sector: Manufacturing
  • CEO Name: Kevin Sayer

Key Statistics

  • Stock Price: $529.42
  • Dividend Yield: 0%
  • Market Capitalization: $50,458,421,828
  • Shares Outstanding: 96,748,901
  • Number of Employees: 5,500
  • Trailing 12-Month EPS: $5.33
  • Trailing 12-Month DPS: $0
  • Payout Ratio: 0.0%

Important Dates

  • Next Earnings Date: 2021-10-27
  • Next Ex-Dividend Date:

Price Trends

  • Current Stock Price: $529.42
  • 52-week high: $528.3
  • 52-week low: $305.63
  • 200-day moving average: $410.91
  • 50-day moving average: $488.17

Performance

  • 1-Month Price Return: 1.2%
  • 3-Month Price Return: 41.2%
  • 6-Month Price Return: 31.1%
  • 1-Year Price Return: 24.5%
  • 2-Year Price Return: 203.9%
  • 5-Year Price Return: 466.1%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast